Efficacy of external beam radiotherapy and targeted therapy with vandenanib in patients with inoperable and progressive medullary thyroid cancer

Cover Page

Cite item

Full Text

Abstract

The study objective is to evaluate modern-era radiotherapy (external beam radiotherapy, EBRT) and target therapy (TT) outcomes for advanced medullary thyroid cancer (MTC).

Materials and methods. Seventy eight consecutive patients with stage IV MTC were evaluated. All of them with relapsing locally advanced or metastatic MTC, 16 had clinically relevant mediastinal involvement, and 59 had distant metastasis; 26 patients received conformal EBRT or intensity-modulated radiotherapy in monomode, 16 patients – conformal EBRT with simultaneous TT with vandenanib, 36 patients – TT in monomode. Median EBRT dose was 60 Gy.

Results. Kaplan–Meier estimates of the median overall survival rate was 14 months for radiotherapy in monomode, 48 months – for conformal EBRT + simultaneous TT with vandenanib, 50 months – for TT in monomode. EBRT and TT allows for significantly shorter periods (median 3.8 weeks), to relieve the symptoms of compression-mediated organs and structures of the neck and mediastinum than in the TT (median 10.2 weeks) (p <0.001).

Conclusion. EBRT and TT provided durable locoregional disease control with limited morbidity.

About the authors

A. D. Kaprin

National Medical Research Radiological Center, Ministry of Health of Russia.

Author for correspondence.
Email: fake@neicon.ru
3 2nd Botkinsky Proezd, Moscow 125284. Russian Federation

S. A. Ivanov

National Medical Research Radiological Center, Ministry of Health of Russia.

Email: fake@neicon.ru
ORCID iD: 0000-0001-7689-6032
3 2nd Botkinsky Proezd, Moscow 125284. Russian Federation

F. E. Sevryukov

National Medical Research Radiological Center, Ministry of Health of Russia.

Email: fake@neicon.ru
ORCID iD: 0000-0002-9756-6275
3 2nd Botkinsky Proezd, Moscow 125284. Russian Federation

I. S. Pimonova

National Medical Research Radiological Center, Ministry of Health of Russia.

Email: fake@neicon.ru
3 2nd Botkinsky Proezd, Moscow 125284. Russian Federation

P. A. Isaev

National Medical Research Radiological Center, Ministry of Health of Russia.

Email: isaev@mrrc.obninsk.ru
ORCID iD: 0000-0001-9831-4814
3 2nd Botkinsky Proezd, Moscow 125284. Russian Federation

N. V. Severskaya

National Medical Research Radiological Center, Ministry of Health of Russia.

Email: fake@neicon.ru
ORCID iD: 0000-0002-9426-8459
3 2nd Botkinsky Proezd, Moscow 125284. Russian Federation

A. A. Ilyin

National Medical Research Radiological Center, Ministry of Health of Russia.

Email: fake@neicon.ru
ORCID iD: 0000-0002-6581-633X
3 2nd Botkinsky Proezd, Moscow 125284. Russian Federation

V. V. Polkin

National Medical Research Radiological Center, Ministry of Health of Russia.

Email: fake@neicon.ru
ORCID iD: 0000-0003-0857-321X
3 2nd Botkinsky Proezd, Moscow 125284. Russian Federation

D. Yu. Siomin

National Medical Research Radiological Center, Ministry of Health of Russia.

Email: fake@neicon.ru
ORCID iD: 0000-0003-0442-6933
3 2nd Botkinsky Proezd, Moscow 125284. Russian Federation

S. V. Vasilkov

National Medical Research Radiological Center, Ministry of Health of Russia.

Email: fake@neicon.ru
ORCID iD: 0000-0002-4423-5640
3 2nd Botkinsky Proezd, Moscow 125284. Russian Federation

D. N. Derbugov

National Medical Research Radiological Center, Ministry of Health of Russia.

Email: fake@neicon.ru
3 2nd Botkinsky Proezd, Moscow 125284. Russian Federation

Yu. A. Panaseikin

National Medical Research Radiological Center, Ministry of Health of Russia.

Email: fake@neicon.ru
3 2nd Botkinsky Proezd, Moscow 125284. Russian Federation

V. S. Medvedev

National Medical Research Radiological Center, Ministry of Health of Russia.

Email: fake@neicon.ru
3 2nd Botkinsky Proezd, Moscow 125284. Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 36990 от  21.07.2009.